Shilpa Medicare
add_icon

Shilpa Medicare

312.80
-19.50
(-5.87%)
Market Cap
6,117.80 Cr
PE Ratio
43.44
Volume
3,67,996.00
Day High - Low
335.60 - 312.00
52W High-Low
1,000.00 - 259.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
6,117.80 Cr
EPS
8.04
PE Ratio
43.44
PB Ratio
2.67
Book Value
124.61
EBITDA
340.20
Dividend Yield
0.15 %
Industry
Healthcare
Return on Equity
3.31
Debt to Equity
0.36
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Shilpa Medicare Limited receives NCLT approval for amalgamation with wholly owned subsidiary Shilpa Therapeutics Private Limited, effective from April 1, 2025.
positive
Steincare and Shilpa Biologicals have signed a strategic partnership deal to enhance biosimilar access across Latin American markets, marking a significant expansion move.
positive
Shilpa Medicare Limited enters binding agreement with Switzerland-based NXI Therapeutics AG for development and supply of New Chemical Entity targeting autoimmune conditions, marking third major international mandate.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57
Growth Rate
Revenue Growth
12.92 %
Net Income Growth
144.69 %
Cash Flow Change
-3.29 %
ROE
85.96 %
ROCE
23.15 %
EBITDA Margin (Avg.)
19.23 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
168
151
177
202
203
168
219
186
231
174
209
191
241
203
192
177
203
163
296
241
229
289
288
200
215
239
306
278
346
269
267
266
266
262
315
289
300
302
349
321
341
328
372
411
Expenses
129
120
137
158
146
139
161
151
171
133
155
159
189
149
128
153
163
132
223
163
175
158
210
171
182
206
243
228
268
241
253
231
227
214
255
222
222
223
258
239
282
231
262
309
EBITDA
39
31
40
44
58
30
58
35
60
40
54
31
53
54
64
24
41
31
73
78
54
131
78
29
33
33
62
50
78
28
14
34
39
48
60
67
79
80
91
82
59
97
110
102
Operating Profit %
23 %
19 %
21 %
21 %
26 %
16 %
23 %
17 %
23 %
20 %
24 %
14 %
20 %
25 %
21 %
12 %
19 %
18 %
23 %
31 %
21 %
29 %
25 %
11 %
12 %
13 %
18 %
16 %
21 %
8 %
4 %
12 %
14 %
18 %
19 %
23 %
24 %
24 %
25 %
25 %
15 %
28 %
29 %
25 %
Depreciation
5
5
6
6
6
7
7
8
8
9
8
9
11
10
10
11
11
11
11
11
12
12
13
14
15
18
19
21
22
22
23
24
26
27
28
27
27
27
28
29
29
29
30
30
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
4
4
5
9
10
12
10
9
10
14
18
18
18
23
26
24
24
26
12
15
19
16
11
Profit Before Tax
32
25
34
37
50
22
50
27
51
31
46
22
41
43
53
11
29
19
62
65
42
115
61
11
8
5
32
19
46
-4
-22
-8
-4
3
9
14
28
29
37
42
15
50
64
61
Tax
10
7
12
10
12
8
12
10
14
9
12
5
10
10
11
-1
6
4
11
11
8
29
16
3
1
4
12
10
17
-6
-4
-1
4
2
8
10
3
15
19
10
1
3
20
16
Net Profit
22
18
22
27
38
14
38
17
37
22
34
16
31
33
42
12
23
15
51
55
34
86
45
8
8
2
20
10
30
2
-19
-7
-8
1
2
5
25
14
18
32
15
47
44
45
EPS in ₹
5.86
4.70
6.05
3.60
4.27
1.92
4.97
2.03
4.33
2.77
4.21
2.29
3.79
4.28
5.22
1.46
2.93
1.93
6.23
6.75
4.24
10.59
5.57
0.94
0.96
0.19
2.45
1.13
3.40
0.10
-2.15
-0.76
-0.93
0.14
0.19
0.53
2.82
1.46
1.83
3.25
1.48
4.79
5.50
2.36

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
905
931
1,472
1,499
1,610
1,989
2,632
2,876
2,904
3,093
3,311
Fixed Assets
316
393
492
534
558
650
1,111
1,342
1,368
1,385
1,418
Current Assets
328
354
730
672
545
624
903
887
770
877
986
Capital Work in Progress
222
92
141
210
429
666
541
506
655
719
822
Investments
65
94
253
140
2
11
21
34
43
40
35
Other Assets
302
352
587
615
621
662
959
993
838
950
1,037
Total Equity & Liabilities
905
931
1,472
1,499
1,610
1,989
2,632
2,876
2,904
3,093
3,311
Current Liabilities
189
222
237
266
253
411
604
612
784
693
674
Non Current Liabilities
154
67
251
154
167
257
561
453
345
600
273
Total Equity
561
642
984
1,080
1,190
1,322
1,468
1,811
1,774
1,800
2,364
Reserve & Surplus
539
632
979
1,077
1,189
1,321
1,471
1,814
1,775
1,800
2,363
Share Capital
8
8
8
8
8
8
8
9
9
9
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
9
3
93
-26
-40
10
79
-98
-7
13
-3
Investing Activities
-196
-106
-257
-10
-196
-290
-404
-286
-232
-171
-198
Operating Activities
69
129
38
45
147
124
47
105
180
137
132
Financing Activities
136
-20
313
-61
10
176
436
83
46
47
63

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
53.25 %
53.25 %
53.25 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
44.39 %
44.39 %
44.33 %
44.23 %
44.23 %
44.23 %
44.23 %
40.13 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.60 %
8.52 %
0.00 %
0.00 %
9.08 %
9.58 %
9.90 %
10.97 %
11.20 %
10.92 %
10.97 %
DIIs
2.95 %
2.05 %
2.29 %
2.15 %
2.12 %
1.01 %
1.01 %
1.01 %
0.61 %
0.54 %
0.00 %
0.41 %
0.06 %
1.59 %
6.13 %
7.61 %
8.18 %
8.27 %
7.55 %
7.46 %
7.67 %
8.33 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.80 %
17.89 %
19.49 %
18.23 %
18.57 %
20.12 %
20.51 %
18.95 %
21.85 %
24.05 %
26.82 %
25.40 %
25.45 %
27.64 %
24.54 %
24.69 %
23.94 %
24.40 %
24.43 %
23.21 %
23.34 %
27.80 %
Others
27.01 %
26.81 %
24.97 %
29.61 %
29.31 %
28.87 %
28.47 %
30.03 %
27.52 %
25.40 %
23.17 %
15.59 %
15.96 %
20.75 %
24.94 %
14.23 %
13.96 %
13.21 %
12.83 %
13.90 %
13.84 %
12.76 %
No of Share Holders
51,277
53,220
46,540
40,592
39,565
39,724
39,097
41,579
46,143
46,869
50,434
44,094
43,630
44,793
44,809
41,072
42,784
49,034
50,108
48,636
52,065
53,799

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.6 0.7 1 1.1 1.1 1.1 0.00 0.00 1 0.00
Dividend Yield (%) 0.26 0.41 0.82 0.66 0.55 0.96 0.00 0.00 0.32 0.00

Announcements

Announcement under Regulation 30 (LODR)-Scheme of Arrangement9 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2026
Revised Attachment To Annexure - I. On Execution Of Agreement With NXI Therapeutics AGFeb 14, 2026
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015Feb 13, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2026
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015Feb 06, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Announcement Under Regulation 30 (LODR)-Meeting UpdatesFeb 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting.Feb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations 2015Jan 30, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 28, 2026
Assignment Of ESG Rating By SES ESG Research Pvt LtdJan 16, 2026
Intimation Under Regulation 30 Of SEBI(LODR) Regulations 2015Jan 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or Ruxolitinib Salts APIDec 30, 2025
Closure of Trading WindowDec 26, 2025
Intimation Under Of Regulation 30 Of The SEBI(LODR) RegulationsDec 12, 2025
USFDA Inspection Of Shilpa Medicare Ltd. Unit IV Jadcherla TelanganaNov 22, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 17, 2025
Announcement Under Regulation 30 Of The SEBI(LODR) Regulations.Nov 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesNov 13, 2025
Outcome Of The Board Meeting Of The Company Held On 13 November 2025Nov 13, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 13 November 2025Nov 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 10, 2025
Announcement Under Regulation 30 Of The SEBI(LODR) Regulations 2015Nov 10, 2025
Announcement Under Regulation 30 Of The SEBI(LODR) Regulations 2015Nov 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Board Meeting Intimation for Consider And Approve Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended 30 September 2025Nov 05, 2025
Announcement Under Regulation 30 & 30(A) Of The SEBI (LODR) Regulations 2015Oct 27, 2025
Intimation Under Regulation 30 Read With Regulation 30A And Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 09, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 07, 2025
Announcement under Regulation 30 (LODR)-AllotmentOct 06, 2025
NSE - In Principle Approval For Bonus IssueSep 29, 2025
Promoter Reclassificion - NOC From BSESep 27, 2025
In-Principle Approval For Bonus IssueSep 26, 2025
Promoter Reclassificaiton - NOC From NSESep 26, 2025
Closure of Trading WindowSep 26, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 24, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 23, 2025
Announcement under Regulation 30 (LODR)-CessationSep 23, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
3
0.00%
0.00%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.97%
0
0.00%
0.12%
WhiteOak Capital Mid Cap Fund Direct - Growth
0.21%
0
0.00%
0.02%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.38%
0
0.00%
0.11%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
0
0.00%
0.00%
ITI Pharma and Healthcare Fund Direct - Growth
0.75%
0
0.00%
0.07%
Bandhan Healthcare Fund Direct - Growth
1.43%
0
0.14%
0.19%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.42%
0
0.00%
0.05%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
0
0.00%
0.00%
HDFC Pharma And Healthcare Fund Direct - Growth
1.68%
0
0.00%
0.12%
ICICI Prudential ELSS Tax Saver Direct Plan - Growth
0.48%
0
0.00%
0.07%
Aditya Birla Sun Life Retirement Fund - The 30s Plan Direct-Growth
1.48%
0
0.00%
0.94%
ICICI Prudential Exports and Services Fund Direct-Growth
0.86%
0
0.00%
-0.07%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.27%
0
0.00%
0.03%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
2.20%
0
0.00%
0.21%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.51%
0
0.00%
0.07%
Samco Active Momentum Fund Direct - Growth
0.00%
0
0.00%
0.00%
Samco Multi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
WhiteOak Capital Balanced Advantage Fund Direct - Growth
0.10%
0
0.00%
0.01%
WhiteOak Capital Balanced Hybrid Fund Direct - Growth
0.12%
0
0.00%
0.01%
WhiteOak Capital ELSS Tax Saver Fund Direct - Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
0.96%
0
0.00%
0.09%

Technical Indicators

RSI(14)
Neutral
43.58
ATR(14)
Volatile
14.63
STOCH(9,6)
Neutral
55.74
STOCH RSI(14)
Neutral
36.45
MACD(12,26)
Bearish
-1.56
ADX(14)
Strong Trend
28.99
UO(9)
Bearish
45.03
ROC(12)
Downtrend And Accelerating
-2.42
WillR(14)
Oversold
-97.66